Your sequencer is not your bottleneck. Find the step that is.
Capital cases for NGS labs get built around instrument throughput, because that is the number the vendor gave you. The step that actually caps most molecular labs is manual library prep, and no instrument quote will ever tell you that.
What the model does with your menu
- Co-loaded flow cells split by fill share, so a run shared across four assays costs each one honestly.
- The reportable-yield funnel — QNS, no-call, requeue, re-analysis — between accession and a signed-out result.
- Reflex paths modeled as what they are: a different assay, with its own cost basis and its own code.
- Every shared resource load-summed across the menu, so the binding constraint is the lab’s, not one assay’s.
There is a fully-modeled clinical genomics / molecular sample lab you can open right now — no signup, every number checkable, and a guided walkthrough that takes you to the answer.
Your archetype is a starting point, not a cage
If your lab sits on the border between two of these — most independent labs do — pick whichever is closest. Setup starts you with a lean set of capabilities for that archetype, and every other capability is a free switch you turn on until the model fits. Nothing is behind a tier, and nothing you turn on can be taken away by the choice you made on day one.
Built for independent commercial labs — molecular and NGS first, and the broad-menu regional labs that run the same economics across a wider menu.